The possible role of ribosomal protein S6 kinase 4 in the senescence of endothelial progenitor cells in diabetes mellitus

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Yin, Zhiyong ^a   Fan, Linni ^a   Huang, Gaosheng ^a   Wang, Haichang ^a   Wang, Zhe ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Endothelial progenitor cell; RSK4; Senescence

Indexed keywords

GLUCOSE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; RIBOSOMAL PROTEIN S6 KINASE 4; S6 KINASE; UNCLASSIFIED DRUG; BETA GALACTOSIDASE; RPS6KA6 PROTEIN, HUMAN;

ARTICLE; CELL AGING; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVITY; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; NONHUMAN; PROTEIN FUNCTION; VASCULAR ENDOTHELIUM; CASE CONTROL STUDY; CELL CULTURE; ENDOTHELIUM CELL; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; METABOLISM; METHODOLOGY; PATHOLOGY; POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STEM CELL; WESTERN BLOTTING;

BETA-GALACTOSIDASE; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL AGING; CELLS, CULTURED; DIABETES MELLITUS; ENDOTHELIAL CELLS; GLUCOSE; HUMANS; POLYMERASE CHAIN REACTION; RESEARCH DESIGN; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA INTERFERENCE; STEM CELLS; TRANSFECTION;

EID: 84856448387     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-12     Document Type: Article

References (37)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275(5302):964-967. 10.1126/science.275.5302.964, 9020076.
2. Loomans CJ, De Koning EJ, Staal FJ, Rabelink TJ, Zonneveld AJ. Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress?. Antioxid Redox Signal 2005, 7(11-12):1468-1475. 10.1089/ars.2005.7.1468, 16356109.
3. Nolan DJ, Ciarrocchi A, Mellick AS, Jaggi JS, Bambino K, Gupta S, Heikamp E, McDevitt MR, Scheinberg DA, Benezra R, et al. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 2007, 21(12):1546-1558. 10.1101/gad.436307, 1891431, 17575055.
4. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, Menegolo M, de Kreutzenberg SV, Tiengo A, Agostini C, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005, 45(9):1449-1457. 10.1016/j.jacc.2004.11.067, 15862417.
5. Mohler ER, Shi Y, Moore J, Bantly A, Hamamdzic D, Yoder M, Rader DJ, Putt M, Zhang L, Parmacek M, et al. Diabetes reduces bone marrow and circulating porcine endothelial progenitor cells, an effect ameliorated by atorvastatin and independent of cholesterol. Cytometry A 2009, 75(1):75-82.
6. Georgescu A. Vascular dysfunction in diabetes: the endothelial progenitor cells as new therapeutic strategy. World J Diabetes 2011, 2(6):92-97. 10.4239/wjd.v2.i6.92, 3158877, 21860692.
7. Saito H, Yamamoto Y, Yamamoto H. Diabetes alters subsets of endothelial progenitor cells that reside in blood, bone marrow and spleen. Am J Physiol Cell Physiol 2011,
8. Jung C, Rafnsson A, Shemyakin A, Bohm F, Pernow J. Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes. Int J Cardiol 2010, 143(3):368-372. 10.1016/j.ijcard.2009.03.075, 19398138.
9. Bozdag-Turan I, Turan RG, Turan CH, Ludovicy S, Akin I, Kische S, Arsoy NS, Schneider H, Ortak J, Rehders T, et al. Relation between the frequency of CD34+ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes. Cardiovasc Diabetol 2011, 10:107. 10.1186/1475-2840-10-107, 3235974, 22118372.
10. Kim HM, Kim KJ, Moon JH, Lee HJ, Chae MK, Chang HJ, Kang ES, Cha BS, Lee HC, Kim YJ, et al. Association between EPCs count and rate of coronary revascularization in asymptomatic type 2 diabetic patients. Acta Diabetol 2011,
11. Grapensparr L, Olerud J, Vasylovska S, Carlsson PO. The therapeutic role of endothelial progenitor cells in Type 1 diabetes mellitus. Regen Med 2011, 6(5):599-605. 10.2217/rme.11.45, 21916595.
12. Hamed S, Brenner B, Roguin A. Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2. Cardiovasc Res 2011, 91(1):9-15. 10.1093/cvr/cvq412, 21186243.
13. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002, 106(22):2781-2786. 10.1161/01.CIR.0000039526.42991.93, 12451003.
14. Dernbach E, Urbich C, Brandes RP, Hofmann WK, Zeiher AM, Dimmeler S. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 2004, 104(12):3591-3597. 10.1182/blood-2003-12-4103, 15161665.
15. Hamed S, Brenner B, Aharon A, Daoud D, Roguin A. Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus. Cardiovasc Diabetol 2009, 8:56. 10.1186/1475-2840-8-56, 2773759, 19878539.
16. Sorrentino SA, Bahlmann FH, Besler C, Muller M, Schulz S, Kirchhoff N, Doerries C, Horvath T, Limbourg A, Limbourg F, et al. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 2007, 116(2):163-173. 10.1161/CIRCULATIONAHA.106.684381, 17592079.
17. Palombo C, Kozakova M, Morizzo C, Gnesi L, Barsotti MC, Spontoni P, Massart F, Salvi P, Balbarini A, Saggese G, et al. Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated Type 1 diabetes. Cardiovasc Diabetol 2011, 10:88. 10.1186/1475-2840-10-88, 3198903, 21981808.
18. Testa R, Ceriello A. Pathogenetic loop between diabetes and cell senescence. Diabetes Care 2007, 30(11):2974-2975. 10.2337/dc07-1534, 17965314.
19. Yntema HG, van den Helm B, Kissing J, van Duijnhoven G, Poppelaars F, Chelly J, Moraine C, Fryns JP, Hamel BC, Heilbronner H, et al. A novel ribosomal S6-kinase (RSK4; RPS6KA6) is commonly deleted in patients with complex X-linked mental retardation. Genomics 1999, 62(3):332-343. 10.1006/geno.1999.6004, 10644430.
20. Dummler BA, Hauge C, Silber J, Yntema HG, Kruse LS, Kofoed B, Hemmings BA, Alessi DR, Frodin M. Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types. J Biol Chem 2005, 280(14):13304-13314. 10.1074/jbc.M408194200, 15632195.
21. Me LL, Vidal F, Gallardo D, Diaz-Fuertes M, Rojo F, Cuatrecasas M, Lopez-Vicente L, Kondoh H, Blanco C, Carnero A, et al. New p53 related genes in human tumors: significant downregulation in colon and lung carcinomas. Oncol Rep 2006, 16(3):603-608.
22. Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, Kerkhoven RM, Madiredjo M, Nijkamp W, Weigelt B, et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004, 428(6981):431-437. 10.1038/nature02371, 15042092.
23. Lopez-Vicente L, Armengol G, Pons B, Coch L, Argelaguet E, Lleonart M, Hernandez-Losa J, de Torres I, Ramon Y, Cajal S. Regulation of replicative and stress-induced senescence by RSK4, which is down-regulated in human tumors. Clin Cancer Res 2009, 15(14):4546-4553. 10.1158/1078-0432.CCR-08-3159, 19584160.
24. Lopez-Vicente L, Pons B, Coch L, Teixido C, Hernandez-Losa J, Armengol G, Ramon YCS. RSK4 Inhibition Results in Bypass of Stress-Induced and Oncogene-Induced Senescence. Carcinogenesis 2011, 32(4):470-476. 10.1093/carcin/bgr003, 21239520.
25. Carriere A, Ray H, Blenis J, Roux PP. The RSK factors of activating the Ras/MAPK signaling cascade. Front Biosci 2008, 13:4258-4275.
26. Niehof M, Borlak J. RSK4 and PAK5 are novel candidate genes in diabetic rat kidney and brain. Mol Pharmacol 2005, 67(3):604-611.
27. Chiba H, Itoh T, Satohisa S, Sakai N, Noguchi H, Osanai M, Kojima T, Sawada N. Activation of p21CIP1/WAF1 gene expression and inhibition of cell proliferation by overexpression of hepatocyte nuclear factor-4alpha. Exp Cell Res 2005, 302(1):11-21. 10.1016/j.yexcr.2004.08.014, 15541721.
28. Maity A, Koumenis C. HIF and MIF-a nifty way to delay senescence?. Genes Dev 2006, 20(24):3337-3341. 10.1101/gad.1506906, 17182862.
29. Itahana K, Campisi J, Dimri GP. Mechanisms of cellular senescence in human and mouse cells. Biogerontology 2004, 5(1):1-10.
30. Rosso A, Balsamo A, Gambino R, Dentelli P, Falcioni R, Cassader M, Pegoraro L, Pagano G, Brizzi MF. p53 Mediates the accelerated onset of senescence of endothelial progenitor cells in diabetes. J Biol Chem 2006, 281(7):4339-4347. 10.1074/jbc.M509293200, 16339764.
31. Kuki S, Imanishi T, Kobayashi K, Matsuo Y, Obana M, Akasaka T. Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase. Circ J 2006, 70(8):1076-1081. 10.1253/circj.70.1076, 16864945.
32. Chen YH, Lin SJ, Lin FY, Wu TC, Tsao CR, Huang PH, Liu PL, Chen YL, Chen JW. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 2007, 56(6):1559-1568. 10.2337/db06-1103, 17389326.
33. Hamed S, Brenner B, Abassi Z, Aharon A, Daoud D, Roguin A. Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitus. Thromb Res 2010, 126(3):166-174. 10.1016/j.thromres.2010.03.002, 20347119.
34. Cubbon RM, Kahn MB, Wheatcroft SB. Effects of insulin resistance on endothelial progenitor cells and vascular repair. Clin Sci (Lond) 2009, 117(5):173-190.
35. Cubbon RM, Rajwani A, Wheatcroft SB. The impact of insulin resistance on endothelial function, progenitor cells and repair. Diab Vasc Dis Res 2007, 4(2):103-111.
36. Desouza CV, Hamel FG, Bidasee K, O'Connell K. Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction. Diabetes 2011, 60(4):1286-1294. 10.2337/db10-0875, 21346178.
37. Everaert BR, Van Craenenbroeck EM, Hoymans VY, Haine SE, Van Nassauw L, Conraads VM, Timmermans JP, Vrints CJ. Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway. Int J Cardiol 2010, 144(3):350-366. 10.1016/j.ijcard.2010.04.018, 20444511.